Marcella Battaglini

Mrs. Marcella Battaglini

DINOGMI Department; Genova University, IRCCS Istituto Giannina Gaslini
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2022 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
MCMichele Clerico
Michele Clerico
IDIrene Dogliotti
Irene Dogliotti
PGPaola Ghione
Paola Ghione
VZVittorio Ruggero Zilioli
Vittorio Ruggero Zilioli
FMFrancesco Merli
Francesco Merli
FCFederica CAVALLO
Federica CAVALLO
Hepatitis B virus reactivation (HBVr) can develop in HBV surface antigen (HBsAg) positive or HBsAg-negative and anti-hepatitis B core antigen antibodies (anti-HBc) positive (past HBV infection) patients receiving immuno-chemotherapy for hematological malignancies. A higher rate of HBVr is associated with the use of rituximab (R) in patients with past HBV infection, thus justifying an antiviral prophylaxis. In this study we evaluated the incidence of HBVr in a real-life cohort of 362 anti-HBc-positive subjects affected by non-Hodgkin lymphoma (NHL), mainly receiving lamivudine (LAM) prophylaxis (93%) and all undergoing a R-containing regimen. A retrospective, multicenter, observational study was conducted in 4 Italian Hematology Departments. The primary endpoint was the incidence of virologic (HBV DNA-positive), serologic (HBsAg-positive) and clinical (ALT increase > 3 × upper limit of normal) HBVr, which occurred in five, four and one patients, respectively, with a total HBVr rate of 1.4%. None of them had to discontinue the chemotherapy program, while two patients required a delay. Treatment-related adverse events (AEs) were reported during LAM prophylaxis in three patients (0.9%). In conclusion, this study confirms the efficacy and safety of LAM prophylaxis in anti-HBc-positive patients undergoing R-containing regimens.

16 December 2025 in European Journal of Paediatric Neurology
Verified
Journal Article
Closed access
ACAndrea Calandrino
Andrea Calandrino
MBMarcella Battaglini
Marcella Battaglini
SCSamuele Caruggi
Samuele Caruggi
IBIrene Bonato
Irene Bonato
PMPaolo Massirio
Paolo Massirio
LRLuca Antonio Ramenghi
Luca Antonio Ramenghi

1 September 2026 in Journal of Pediatric Gastroenterology and Nutrition
Verified
Journal Article
Closed access
SCSamuele Caruggi
Samuele Caruggi
Andrea CalandrinoAndrea Calandrino
Andrea Calandrino
MBMarcella Battaglini
Marcella Battaglini
FBFrancesca Baudi
Francesca Baudi
BLBarbara Lionetti
Barbara Lionetti
LRLuca Antonio Ramenghi
Luca Antonio Ramenghi